A detailed history of Aqr Capital Management LLC transactions in Mannkind Corp stock. As of the latest transaction made, Aqr Capital Management LLC holds 43,593 shares of MNKD stock, worth $306,022. This represents 0.0% of its overall portfolio holdings.

Number of Shares
43,593
Previous 42,730 2.02%
Holding current value
$306,022
Previous $223,000 22.42%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.01 - $6.7 $4,323 - $5,782
863 Added 2.02%
43,593 $273,000
Q2 2024

Aug 14, 2024

BUY
$4.05 - $5.43 $13,016 - $17,452
3,214 Added 8.13%
42,730 $223,000
Q1 2024

May 15, 2024

BUY
$3.25 - $5.27 $4,387 - $7,114
1,350 Added 3.54%
39,516 $179,000
Q4 2023

Feb 14, 2024

SELL
$3.34 - $4.29 $3,780 - $4,856
-1,132 Reduced 2.88%
38,166 $138,000
Q3 2023

Nov 14, 2023

SELL
$3.91 - $5.45 $11,952 - $16,660
-3,057 Reduced 7.22%
39,298 $162,000
Q2 2023

Aug 14, 2023

SELL
$3.72 - $4.79 $394 - $507
-106 Reduced 0.25%
42,355 $172,000
Q1 2023

May 15, 2023

BUY
$3.95 - $5.63 $14,516 - $20,690
3,675 Added 9.48%
42,461 $174,000
Q4 2022

Feb 14, 2023

SELL
$3.02 - $5.37 $2,388 - $4,247
-791 Reduced 2.0%
38,786 $204,000
Q3 2022

Nov 14, 2022

BUY
$2.99 - $4.35 $179 - $261
60 Added 0.15%
39,577 $122,000
Q1 2022

May 16, 2022

SELL
$2.62 - $4.45 $25,571 - $43,432
-9,760 Reduced 19.81%
39,517 $145,000
Q4 2020

Feb 16, 2021

BUY
$1.79 - $4.04 $17,470 - $39,430
9,760 Added 24.7%
49,277 $154,000
Q3 2020

Nov 16, 2020

SELL
$1.56 - $2.08 $27,381 - $36,508
-17,552 Reduced 30.76%
39,517 $74,000
Q2 2018

Aug 14, 2018

BUY
$1.59 - $2.38 $90,739 - $135,824
57,069 New
57,069 $108,000

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.81B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.